Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024
Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organicQ2 GAAP and.
Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4.
/PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance.
New cardiac procedure performed in Mackay for first time whitsundaytimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whitsundaytimes.com.au Daily Mail and Mail on Sunday newspapers.